Supplementary Table S3 from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
收藏NIAID Data Ecosystem2026-05-16 收录
数据链接：
官方服务：
资源简介：
Supplementary Table S3: Baseline Tumor pFGFR3 IHC Intensity
创建时间：
2017-06-15
